Investing in development-stage biotech companies is a lot like playing the lottery. First of all, it's a challenge trying to divine the company's scientific advantage.

Retail investors are notorious for chasing performance, and they may be at it once again. Over the last three years, foreign mutual funds have posted annual returns twice those notched by the S&P 500, prompting investors to dump shares of U.S...

Pay close attention to the customer when you’re picking stocks. No, not your customer (though that’s probably a good idea, too)—the customer of the company whose stock you want to buy. Here’s why: Companies that get high...

Private equity is a hot investment these days. And while you may be referring your ultra-high-net-worth clients to established private equity firms, don't be surprised if a wealthy client asks you for advice on a private investment opportunity...

Is government bad for business? One fund manager thinks so.

Canada represents the best and safest way to invest in the long-term commodity bull market as well as growth in Asia.

Position your clients to survive a 1970's style capital markets storm

Way back in 1998, when stocks were hot, investment-biker and former Soros-partner Jim Rogers launched a commodity index fund, predicting a flat-out bull market in a wide range of commodities. How right Rogers was, again.

If 'insiders' in interest-rate sensitive industries are buying, should you?

Genetically modified crops scare uninformed consumers. But not investors. Here's why